KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, W. Lloyd Clark, MD, discusses positive results from three clinical trials investigating NT-501 for macular telangiectasia type ...

There are two types of RD: rhegmatogenous and nonrhegmatogenous. The distinguishing characteristic is the presence or absence of a full-thickness retinal break (rhegma) (Figure 1). In ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of ...

Ozempic (semaglutide) Glucagon-like peptide-1 receptor agonist To reduce the risk of sustained estimated glomerular filtration rate decline, end-stage kidney disease, and cardiovascular death in ...